BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8383879)

  • 21. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination.
    Hollenberg SM; Cheng PF; Weintraub H
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8028-32. PubMed ID: 8396258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and modulation in vivo of helix-loop-helix protein-protein interactions.
    Finkel T; Duc J; Fearon ER; Dang CV; Tomaselli GF
    J Biol Chem; 1993 Jan; 268(1):5-8. PubMed ID: 8380166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myogenic basic helix-loop-helix proteins regulate the expression of peroxisomal proliferator activated receptor-gamma coactivator-1alpha.
    Chang JH; Lin KH; Shih CH; Chang YJ; Chi HC; Chen SL
    Endocrinology; 2006 Jun; 147(6):3093-106. PubMed ID: 16527841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E2F1 inhibition of transcription activation by myogenic basic helix-loop-helix regulators.
    Wang J; Huang Q; Tang W; Nadal-Ginard B
    J Cell Biochem; 1996 Sep; 62(3):405-10. PubMed ID: 8872611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.
    Yang Z; MacQuarrie KL; Analau E; Tyler AE; Dilworth FJ; Cao Y; Diede SJ; Tapscott SJ
    Genes Dev; 2009 Mar; 23(6):694-707. PubMed ID: 19299559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The muscle transcription factor MyoD promotes osteoblast differentiation by stimulation of the Osterix promoter.
    Hewitt J; Lu X; Gilbert L; Nanes MS
    Endocrinology; 2008 Jul; 149(7):3698-707. PubMed ID: 18372333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD.
    Horwitz M
    Exp Cell Res; 1996 Jul; 226(1):170-82. PubMed ID: 8660953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant.
    Peterson CA; Gordon H; Hall ZW; Paterson BM; Blau HM
    Cell; 1990 Aug; 62(3):493-502. PubMed ID: 1696180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis.
    Davis RL; Cheng PF; Lassar AB; Thayer M; Tapscott S; Weintraub H
    Princess Takamatsu Symp; 1989; 20():267-78. PubMed ID: 2562185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early stages of myogenesis as seen through the action of the myf-5 gene].
    Buckingham M
    C R Seances Soc Biol Fil; 1997; 191(1):43-54. PubMed ID: 9181127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding.
    Li S; Chen K; Zhang Y; Barnes SD; Jaichander P; Zheng Y; Hassan M; Malladi VS; Skapek SX; Xu L; Bassel-Duby R; Olson EN; Liu N
    Genes Dev; 2019 Jun; 33(11-12):626-640. PubMed ID: 30975722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CAIII a marker for early myogenesis: analysis of expression in cultured myogenic cells.
    Tweedie S; Morrison K; Charlton J; Edwards YH
    Somat Cell Mol Genet; 1991 May; 17(3):215-28. PubMed ID: 1904630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A point mutation in the MyoD basic domain imparts c-Myc-like properties.
    Van Antwerp ME; Chen DG; Chang C; Prochownik EV
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9010-4. PubMed ID: 1329087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repression of muscle-specific gene activation by the murine Twist protein.
    Hebrok M; Füchtbauer A; Füchtbauer EM
    Exp Cell Res; 1997 May; 232(2):295-303. PubMed ID: 9168805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel functional co-operation between MyoD, MEF2 and TRalpha1 is sufficient for the induction of GLUT4 gene transcription.
    Santalucía T; Moreno H; Palacín M; Yacoub MH; Brand NJ; Zorzano A
    J Mol Biol; 2001 Nov; 314(2):195-204. PubMed ID: 11718554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage.
    Yu SJ; Zheng L; Ladanyi M; Asa SL; Ezzat S
    Clin Cancer Res; 2004 Oct; 10(19):6750-8. PubMed ID: 15475466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of muscle cell growth and differentiation by the MyoD family of helix-loop-helix proteins.
    Li L; Olson EN
    Adv Cancer Res; 1992; 58():95-119. PubMed ID: 1312291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD.
    Lu J; Webb R; Richardson JA; Olson EN
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):552-7. PubMed ID: 9892671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-specific expression of the skeletal alpha-actin gene involves sequences that can function independently of MyoD and Id.
    Muscat GE; Emery J; Collie ES
    Gene Expr; 1992; 2(3):241-57. PubMed ID: 1333317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
    Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
    Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.